A single dose of the Biontech/Pfizer BNT162b2 vaccine protected elderly residents from severe COVID-19 during a SARS-coronavirus-2 outbreak in a senior citizen home in Germany.

Rolf SchwarzerSabine D FreysNick NeuwingerNina BeikertBettina EberspächerAnke Edelmann Marta ZuchowskiInga SlothouwerAngela SteinKathrin Theil Peter Menzel Jörg Hofmann

Published in: Immunity, inflammation and disease (2021)

In summary, our data show that partial vaccination prevented severe COVID-19 among the residents during this local SARS-CoV-2 outbreak, suggesting a high effectiveness of even a single vaccine dose, but also emphasize that asymptomatic individuals might still be carriers/spreaders.

Keyphrases

sars cov
respiratory syndrome coronavirus
early onset
coronavirus disease
healthcare
randomized controlled trial
systematic review
electronic health record
big data
middle aged
drug induced
machine learning
deep learning
data analysis